Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 22, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions
Mitochondrial DiseasesMitochondrial MyopathiesMitochondrial EncephalomyopathiesMELASMERRF
Interventions
BEHAVIORAL

Promoting Resilience in Stress Management (PRISM)

This program teaches the four pillars of resilience (stress management, goal setting, cognitive restructuring, and benefit-finding) in a one-on-one training program consisting of four 20-30 minute sessions occurring once weekly.

BEHAVIORAL

Clinical-focused narrative (CFN)

This program consists of questions posed to adults with primary mitochondrial disease at regular mitochondrial medicine center visits. Specific topics will be discussed at each session. This consists four 20-30 minute sessions occurring once weekly.

Trial Locations (1)

19104

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

North American Mitochondrial Disease Consortium (NAMDC)

UNKNOWN

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT06051448 - Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD). | Biotech Hunter | Biotech Hunter